Premium
Nonprofit model for drug discovery and development
Author(s) -
Frank Gregory Daniel,
Jong Ling,
Collins Nathan,
Spack Edward G.
Publication year - 2007
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.20181
Subject(s) - drug discovery , drug development , variety (cybernetics) , drug , government (linguistics) , business , institution , pharmacology , medicine , computer science , political science , biology , bioinformatics , linguistics , philosophy , artificial intelligence , law
SRI International, a nonendowed, nonprofit research institution, has developed a successful model for drug discovery and development using funding from a variety of sources. We have vertically integrated basic and applied research, drug discovery, and preclinical drug development expertise and capabilities. Funding sources include state and federal government grants and contracts, and our unique model allows us to translate our discoveries into clinical‐ready drug candidates. Drug Dev Res 68:186–196, 2007. © 2007 Wiley‐Liss, Inc.